307 related articles for article (PubMed ID: 30447840)
21. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
Ellis CL; Partin AW; Han M; Epstein JI
J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
[TBL] [Abstract][Full Text] [Related]
23. Prognostic influence of the third Gleason grade in prostatectomy specimens.
Cedeño Díaz OM; Fernández Aceñero MJ; Alvarez Fernández E
Urol Oncol; 2012; 30(4):386-90. PubMed ID: 21292510
[TBL] [Abstract][Full Text] [Related]
24. Re: Prostate Biopsy Specimens with Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
Taneja SS
J Urol; 2016 Mar; 195(3):627. PubMed ID: 26887707
[No Abstract] [Full Text] [Related]
25. Radical prostatectomy for carcinoma of the prostate.
Ohori M; Kattan M; Scardino PT; Wheeler TM
Mod Pathol; 2004 Mar; 17(3):349-59. PubMed ID: 14765206
[TBL] [Abstract][Full Text] [Related]
26. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
27. Update on prostate pathology.
Osunkoya AO
Pathology; 2012 Aug; 44(5):391-406. PubMed ID: 22772344
[TBL] [Abstract][Full Text] [Related]
28. Comparative histopathological characterization of prostate cancer in Saudi patients by conventional and 2005 ISUP modified gleason systems.
Al Suhaibani ES; Kizilbash NA; Al Beladi F
Asian Pac J Cancer Prev; 2014; 15(24):10923-6. PubMed ID: 25605202
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting prostatic biopsy Gleason sum under grading.
Stackhouse DA; Sun L; Schroeck FR; Jayachandran J; Caire AA; Acholo CO; Robertson CN; Albala DM; Polascik TJ; Donatucci CF; Maloney KE; Moul JW
J Urol; 2009 Jul; 182(1):118-22; discussion 123-4. PubMed ID: 19447436
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in prostate cancer].
Bonkhoff H
Pathologe; 2005 Nov; 26(6):433-43. PubMed ID: 16205900
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
Cole AI; Morgan TM; Spratt DE; Palapattu GS; He C; Tomlins SA; Weizer AZ; Feng FY; Wu A; Siddiqui J; Chinnaiyan AM; Montgomery JS; Kunju LP; Miller DC; Hollenbeck BK; Wei JT; Mehra R
J Urol; 2016 Aug; 196(2):405-11. PubMed ID: 26920466
[TBL] [Abstract][Full Text] [Related]
32. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
[TBL] [Abstract][Full Text] [Related]
33. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
Cheng L; Koch MO; Juliar BE; Daggy JK; Foster RS; Bihrle R; Gardner TA
J Clin Oncol; 2005 May; 23(13):2911-7. PubMed ID: 15860849
[TBL] [Abstract][Full Text] [Related]
34. Staging of prostatic adenocarcinoma with radical prostatectomy specimens in Pakistan.
Memon A; Ahmad Z; Qureshi A; Ahsan A; Barakzai A; Bhurgri Y
Asian Pac J Cancer Prev; 2009; 10(4):551-4. PubMed ID: 19827867
[TBL] [Abstract][Full Text] [Related]
35. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
[TBL] [Abstract][Full Text] [Related]
36. [Gleason grading: diagnostic criteria and clinical implications].
Bonkhoff H
Pathologe; 2005 Nov; 26(6):422-32. PubMed ID: 16215708
[TBL] [Abstract][Full Text] [Related]
37. Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: an Indian experience.
Singh P; Dogra PN; Gupta NP; Nayyar R; Seth A; Javali TD; Kumar R
Indian J Cancer; 2011; 48(4):483-7. PubMed ID: 22293265
[TBL] [Abstract][Full Text] [Related]
38. Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens.
Mazzucchelli R; Barbisan F; Tarquini LM; Filosa A; Campanini N; Galosi AB
Anal Quant Cytol Histol; 2005 Jun; 27(3):125-33. PubMed ID: 16121633
[TBL] [Abstract][Full Text] [Related]
39. Premalignancy in Prostate Cancer: Rethinking What we Know.
De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
[TBL] [Abstract][Full Text] [Related]
40. Foamy gland adenocarcinoma of the prostate: incidence, Gleason grade, and early clinical outcome.
Hudson J; Cao D; Vollmer R; Kibel AS; Grewal S; Humphrey PA
Hum Pathol; 2012 Jul; 43(7):974-9. PubMed ID: 22221706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
